194 related articles for article (PubMed ID: 36864577)
41. Identification, characterization, and biological relevance of prostate cancer stem cells from clinical specimens.
Kasper S
Urol Oncol; 2009; 27(3):301-3. PubMed ID: 19414117
[TBL] [Abstract][Full Text] [Related]
42. Research progression of CD133 as a marker of cancer stem cells.
Zhang H; Li SY
Chin J Cancer; 2010 Mar; 29(3):243-7. PubMed ID: 20193104
[TBL] [Abstract][Full Text] [Related]
43. Antioxidant Mechanisms and ROS-Related MicroRNAs in Cancer Stem Cells.
Dando I; Cordani M; Dalla Pozza E; Biondani G; Donadelli M; Palmieri M
Oxid Med Cell Longev; 2015; 2015():425708. PubMed ID: 26064420
[TBL] [Abstract][Full Text] [Related]
44. Lectin biosensors in cancer glycan biomarker detection.
Silva MLS
Adv Clin Chem; 2019; 93():1-61. PubMed ID: 31655728
[TBL] [Abstract][Full Text] [Related]
45. Glycosylated proteins with abnormal glycosylation changes are potential biomarkers for early diagnosis of breast cancer.
Chang X; Obianwuna UE; Wang J; Zhang H; Qi G; Qiu K; Wu S
Int J Biol Macromol; 2023 May; 236():123855. PubMed ID: 36868337
[TBL] [Abstract][Full Text] [Related]
46. Stemming cancer: functional genomics of cancer stem cells in solid tumors.
Regenbrecht CR; Lehrach H; Adjaye J
Stem Cell Rev; 2008 Dec; 4(4):319-28. PubMed ID: 18561035
[TBL] [Abstract][Full Text] [Related]
47. Mechanisms of cisplatin resistance and targeting of cancer stem cells: Adding glycosylation to the equation.
Ferreira JA; Peixoto A; Neves M; Gaiteiro C; Reis CA; Assaraf YG; Santos LL
Drug Resist Updat; 2016 Jan; 24():34-54. PubMed ID: 26830314
[TBL] [Abstract][Full Text] [Related]
48. Therapeutic approaches targeting cancer stem cells.
Pan Y; Ma S; Cao K; Zhou S; Zhao A; Li M; Qian F; Zhu C
J Cancer Res Ther; 2018; 14(7):1469-1475. PubMed ID: 30589025
[TBL] [Abstract][Full Text] [Related]
49. A Systematic Review on the Implications of O-linked Glycan Branching and Truncating Enzymes on Cancer Progression and Metastasis.
Gupta R; Leon F; Rauth S; Batra SK; Ponnusamy MP
Cells; 2020 Feb; 9(2):. PubMed ID: 32075174
[TBL] [Abstract][Full Text] [Related]
50. Potential role of cancer stem cells as biomarkers and therapeutic targets in cervical cancer.
Sudhalkar N; Rathod NP; Mathews A; Chopra S; Sriram H; Shrivastava SK; Goda JS
Cancer Rep (Hoboken); 2019 Apr; 2(2):e1144. PubMed ID: 32721115
[TBL] [Abstract][Full Text] [Related]
51. Post-translational modifications in tumor biomarkers: the next challenge for aptamers?
Díaz-Fernández A; Miranda-Castro R; de-Los-Santos-Álvarez N; Lobo-Castañón MJ
Anal Bioanal Chem; 2018 Mar; 410(8):2059-2065. PubMed ID: 29353432
[TBL] [Abstract][Full Text] [Related]
52. A novel reporter construct for screening small molecule inhibitors that specifically target self-renewing cancer cells.
Shanmugam G; Mohan A; Kumari K; Louis JM; Soumya Krishnan U; Balagopal PG; George NA; Sebastian P; Maliekal TT
Exp Cell Res; 2019 Oct; 383(2):111551. PubMed ID: 31401066
[TBL] [Abstract][Full Text] [Related]
53. Potential of N-glycan in cell adhesion and migration as either a positive or negative regulator.
Gu J; Taniguchi N
Cell Adh Migr; 2008; 2(4):243-5. PubMed ID: 19262156
[TBL] [Abstract][Full Text] [Related]
54. Coordination of self-renewal in glioblastoma by integration of adhesion and microRNA signaling.
Alvarado AG; Turaga SM; Sathyan P; Mulkearns-Hubert EE; Otvos B; Silver DJ; Hale JS; Flavahan WA; Zinn PO; Sinyuk M; Li M; Guda MR; Velpula KK; Tsung AJ; Nakano I; Vogelbaum MA; Majumder S; Rich JN; Lathia JD
Neuro Oncol; 2016 May; 18(5):656-66. PubMed ID: 26374689
[TBL] [Abstract][Full Text] [Related]
55. The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells.
Bidlingmaier S; Zhu X; Liu B
J Mol Med (Berl); 2008 Sep; 86(9):1025-32. PubMed ID: 18535813
[TBL] [Abstract][Full Text] [Related]
56. Cancer stem cells in solid tumors.
Ailles LE; Weissman IL
Curr Opin Biotechnol; 2007 Oct; 18(5):460-6. PubMed ID: 18023337
[TBL] [Abstract][Full Text] [Related]
57. Biomarkers and targeted therapy for cancer stem cells.
Liu Y; Wang H
Trends Pharmacol Sci; 2024 Jan; 45(1):56-66. PubMed ID: 38071088
[TBL] [Abstract][Full Text] [Related]
58. The Hippo transducer TAZ promotes epithelial to mesenchymal transition and cancer stem cell maintenance in oral cancer.
Li Z; Wang Y; Zhu Y; Yuan C; Wang D; Zhang W; Qi B; Qiu J; Song X; Ye J; Wu H; Jiang H; Liu L; Zhang Y; Song LN; Yang J; Cheng J
Mol Oncol; 2015 Jun; 9(6):1091-105. PubMed ID: 25704916
[TBL] [Abstract][Full Text] [Related]
59. Pancreatic cancer stem cells.
Lee CJ; Dosch J; Simeone DM
J Clin Oncol; 2008 Jun; 26(17):2806-12. PubMed ID: 18539958
[TBL] [Abstract][Full Text] [Related]
60. Cancer stem cells: Recent insights and therapies.
Zhou H; Tan L; Liu B; Guan XY
Biochem Pharmacol; 2023 Mar; 209():115441. PubMed ID: 36720355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
